ciladopa

Ciladopa (developmental code name AY-27,110) is a dopamine agonist with a similar chemical structure to dopamine. It was under investigation as an antiparkinsonian agent but was discontinued due to concerns of tumorogenesis in rodents.

Chemical data

Formula: C21H26N2O4
Molecular weight: 370.4 g/mol
IUPAC name: 2-[4-[(2S)-2-(3,4-dimethoxyphenyl)-2-hydroxyethyl]piperazin-1-yl]cyclohepta-2,4,6-trien-1-one

via PubChem

Drug data · ChEMBL

Max clinical phase: Phase 2
Molecule type: Small molecule

via ChEMBL · EBI

Wikidata facts

Mass: 370.189

Show 4 more facts

chemical formula: C₂₁H₂₆N₂O₄
canonical SMILES: COC1=C(C=C(C=C1)C(CN2CCN(CC2)C3=CC=CC=CC3=O)O)OC
isomeric SMILES: COC1=C(C=C(C=C1)[C@@H](CN2CCN(CC2)C3=CC=CC=CC3=O)O)OC
Commons category: Ciladopa

Sources (2)

via Wikidata · CC0

~1 min read

Article

1 sections

Contents

References

{{Drugbox | IUPAC_name = 2-{4-[(2S)-2-(3,4-dimethoxyphenyl)-2-hydroxyethyl]piperazin-1-yl}cyclohepta-2,4,6-trien-1-one | image = Ciladopa Structure.svg | image_class = skin-invert-image

| tradename = | pregnancy_category = | legal_status = Uncontrolled | routes_of_administration = Oral